HOLOGIC, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.71 USD | -0.58% |
|
+2.39% | +7.36% |
Presentation Operator MessageOperator (Operator)Good afternoon, and welcome to the Hologic 2Q ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows:
- molecular diagnostics (46.7%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin;
- breast health (35.5%): digital mammography and breast biopsy solutions and systems;
- gynecological surgery (15%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures;
- bone health (2.8%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment.
Net sales break down by source of revenue between sales of products (81.4%) and services (18.6%).
Net sales are distributed geographically as follows: the United States (75.9%), Europe (12.9%), Asia/Pacific (6.3%) and other (4.9%).
Calendar
2024-05-02
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
76.71
USD
Average target price
84.27
USD
Spread / Average Target
+9.86%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.36% | 18.01B | |
| +8.78% | 220B | |
| +8.24% | 185B | |
| +11.16% | 133B | |
| +26.12% | 107B | |
| +0.65% | 62.91B | |
| +16.21% | 53.34B | |
| -1.63% | 47.71B | |
| -1.11% | 40.29B | |
| +12.16% | 39.57B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Transcript : Hologic, Inc., Q2 2022 Earnings Call, Apr 27, 2022
